New patent expiration for Cubist Pharms drug ENTEREG
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - Ein Podcast von DrugPatentWatch
Kategorien:
Annual Drug Patent Expirations for ENTEREG Entereg is a drug marketed by Cubist Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge. Drug patent litigation for ENTEREG. This drug has eighteen patent family members in fourteen countries. The generic […] Source
